David Sheppard: Ledger

Stories naming David Sheppard. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.

Role	Organisation	Sources
Director	Sheppard R&D Consultancy Ltd.	Brandon Capital portfolio

Series A $81m

Entact Bio Launches with $81 Million Series A to Develop Precision Medicines for Targeted Protein Enhancement

Biotech startup Entact Bio has launched with an $81 million Series A funding its Encompass platform, which designs molecules that enhance protein function, backed by Qiming Venture Partners USA, venBio Partners and others.

Brandon Capital portfolio Tue 6 Dec 2022 Entact Bio Citadel Dana-Farber Cancer Institute Harvard Medical School Sheppard R&D Consultancy Ltd.University of Liverpool Abingworth Brandon Capital WEHI David Komander David Sheppard Jarrod Marto Michael Clague Sara Buhrlage Sylvie Urbé Ueli Nachbur Victoria Richon

David Sheppard

Roles

Coverage

Entact Bio Launches with $81 Million Series A to Develop Precision Medicines for Targeted Protein Enhancement